Beobachtungsplan, NIS 691: Prospective Analysis of the Efficiency of Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura - A national prospective, multicentre observational study (REACT2020)

Datei

• Artikel "Beobachtungsplan, NIS 691: Prospective Analysis of the Efficiency of Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura - A national prospective, multicentre observational study (REACT2020)"Herunterladen(PDF, 6MB, Datei ist nicht barrierefrei)